JSF Financial’s iShares Biotechnology ETF IBB Stock Holding History

JSF Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,873	Closed	-$209K	–	64
2019 Q1	$209K	Buy	+1,873	New	+$205K	0.23%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSF Financial's IBB Position: Q2 2019 in Review

JSF Financial sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 1,873 shares — an estimated $209K sold.

JSF Financial first reported a position in IBB in Q1 2019 and held it in 1 quarter. The position peaked at $209K in Q1 2019. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

JSF Financial reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
JSF Financial sold 1,873 iShares Biotechnology ETF shares in Q2 2019, an estimated $209K.
JSF Financial first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 1 quarter.
JSF Financial's iShares Biotechnology ETF position peaked at $209K in Q1 2019.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on JSF Financial's 13F filing for Q2 2019, filed 27 Feb 2020.